Alexei Savchenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexei Savchenko has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
Elena Evdokimova
Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, Canada
11 shared publications- Peter J. Stogios
Department of Chemical Engineering and Applied Chemistry University of Toronto Canada
10 shared publications Tatiana Skarina
M.G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster University, 1280 Main St W, Hamilton, Ontario, Canada L8S 4K1
10 shared publicationsXiaohui Xu
From the Department of Chemical Engineering and Applied Chemistry, University of Toronto, 200 College Street, Toronto, Ontario M5S 3E5, Canada
7 shared publicationsHong Cui
From the Department of Chemical Engineering and Applied Chemistry, University of Toronto, 200 College Street, Toronto, Ontario M5S 3E5, Canada
5 shared publicationsMariya Morar
Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, Canada
4 shared publications
Latest Publications
- Open Access
- 1 December 2016
- Published by Springer Nature in Molecular Systems Biology
- Vol. 12 (12) , 893
Diverse mechanisms of metaeffector activity in an intracellular bacterial pathogen, Legionella pneumophila
Pathogens deliver complex arsenals of translocated effector proteins to host cells during infection, but the extent to which these proteins are regulated once inside the eukaryotic cell remains poorly defined. Among all bacterial pathogens, Legionella pneumophila maintains the largest known set of translocated substrates, delivering over 300 proteins to the host cell via its Type IVB, Icm/Dot translocation system. Backed by a few notable examples of effector–effector regulation in L. pneumophila , we sought to define the extent of this phenomenon through a systematic analysis of effector–effector functional interaction. We used Saccharomyces cerevisiae , an established proxy for the eukaryotic host, to query > 108,000 pairwise genetic interactions between two compatible expression libraries of ~330 L. pneumophila‐ translocated substrates. While capturing all known examples of effector–effector suppression, we identify fourteen novel translocated substrates that suppress the activity of other bacterial effectors and one pair with synergistic activities. In at least nine instances, this regulation is direct—a hallmark of an emerging class of proteins called metaeffectors, or “effectors of effectors”. Through detailed structural and functional analysis, we show that metaeffector activity derives from a diverse range of mechanisms, shapes evolution, and can be used to reveal important aspects of each cognate effector's function. Metaeffectors, along with other, indirect, forms of effector–effector modulation, may be a common feature of many intracellular pathogens—with unrealized potential to inform our understanding of how pathogens regulate their interactions with the host cell.
- 1 December 2016
- Published by Springer Nature in Molecular Systems Biology
- Vol. 12 (12) , 893
Open AccessDiverse mechanisms of metaeffector activity in an intracellular bacterial pathogen, Legionella pneumophila
Pathogens deliver complex arsenals of translocated effector proteins to host cells during infection, but the extent to which these proteins are regulated once inside the eukaryotic cell remains poorly defined. Among all bacterial pathogens, Legionella pneumophila maintains the largest known set of translocated substrates, delivering over 300 proteins to the host cell via its Type IVB, Icm/Dot translocation system. Backed by a few notable examples of effector–effector regulation in L. pneumophila , we sought to define the extent of this phenomenon through a systematic analysis of effector–effector functional interaction. We used Saccharomyces cerevisiae , an established proxy for the eukaryotic host, to query > 108,000 pairwise genetic interactions between two compatible expression libraries of ~330 L. pneumophila‐ translocated substrates. While capturing all known examples of effector–effector suppression, we identify fourteen novel translocated substrates that suppress the activity of other bacterial effectors and one pair with synergistic activities. In at least nine instances, this regulation is direct—a hallmark of an emerging class of proteins called metaeffectors, or “effectors of effectors”. Through detailed structural and functional analysis, we show that metaeffector activity derives from a diverse range of mechanisms, shapes evolution, and can be used to reveal important aspects of each cognate effector's function. Metaeffectors, along with other, indirect, forms of effector–effector modulation, may be a common feature of many intracellular pathogens—with unrealized potential to inform our understanding of how pathogens regulate their interactions with the host cell.
- 10 November 2016
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 3 (2) , 132-143
Structural and Biochemical Characterization of Acinetobacter spp. Aminoglycoside Acetyltransferases Highlights Functional and Evolutionary Variation among Antibiotic Resistance Enzymes
Modification of aminoglycosides by N-acetyltransferases (AACs) is one of the major mechanisms of resistance to these antibiotics in human bacterial pathogens. More than 50 enzymes belonging to the AAC(6′) subfamily have been identified in Gram-negative and Gram-positive clinical isolates. Our understanding of the molecular function and evolutionary origin of these resistance enzymes remains incomplete. Here we report the structural and enzymatic characterization of AAC(6′)-Ig and AAC(6′)-Ih from Acinetobacter spp. The crystal structure of AAC(6′)-Ig in complex with tobramycin revealed a large substrate-binding cleft remaining partially unoccupied by the substrate, which is in stark contrast with the previously characterized AAC(6′)-Ib enzyme. Enzymatic analysis indicated that AAC(6′)-Ig and -Ih possess a broad specificity against aminoglycosides but with significantly lower turnover rates as compared to other AAC(6′) enzymes. Structure- and function-informed phylogenetic analysis of AAC(6′) enzymes led to identification of at least three distinct subfamilies varying in oligomeric state, active site composition, and drug recognition mode. Our data support the concept of AAC(6′) functionality originating through convergent evolution from diverse Gcn5-related-N-acetyltransferase (GNAT) ancestral enzymes, with AAC(6′)-Ig and -Ih representing enzymes that may still retain ancestral nonresistance functions in the cell as provided by their particular active site properties.
- 10 November 2016
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 3 (2) , 132-143
Structural and Biochemical Characterization of Acinetobacter spp. Aminoglycoside Acetyltransferases Highlights Functional and Evolutionary Variation among Antibiotic Resistance Enzymes
Modification of aminoglycosides by N-acetyltransferases (AACs) is one of the major mechanisms of resistance to these antibiotics in human bacterial pathogens. More than 50 enzymes belonging to the AAC(6′) subfamily have been identified in Gram-negative and Gram-positive clinical isolates. Our understanding of the molecular function and evolutionary origin of these resistance enzymes remains incomplete. Here we report the structural and enzymatic characterization of AAC(6′)-Ig and AAC(6′)-Ih from Acinetobacter spp. The crystal structure of AAC(6′)-Ig in complex with tobramycin revealed a large substrate-binding cleft remaining partially unoccupied by the substrate, which is in stark contrast with the previously characterized AAC(6′)-Ib enzyme. Enzymatic analysis indicated that AAC(6′)-Ig and -Ih possess a broad specificity against aminoglycosides but with significantly lower turnover rates as compared to other AAC(6′) enzymes. Structure- and function-informed phylogenetic analysis of AAC(6′) enzymes led to identification of at least three distinct subfamilies varying in oligomeric state, active site composition, and drug recognition mode. Our data support the concept of AAC(6′) functionality originating through convergent evolution from diverse Gcn5-related-N-acetyltransferase (GNAT) ancestral enzymes, with AAC(6′)-Ig and -Ih representing enzymes that may still retain ancestral nonresistance functions in the cell as provided by their particular active site properties.
- Open Access
- 1 July 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (27) , 14120-14133
Biochemical and Structural Characterization of a Five-domain GH115 α-Glucuronidase from the Marine Bacterium Saccharophagus degradans 2-40T
- 1 July 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (27) , 14120-14133
Open AccessBiochemical and Structural Characterization of a Five-domain GH115 α-Glucuronidase from the Marine Bacterium Saccharophagus degradans 2-40T
- Open Access
- 22 April 2016
- Published by Springer Nature in Nature Communications
- Vol. 7 (1) , 11343
Rifampin phosphotransferase is an unusual antibiotic resistance kinase
Rifampin (RIF) phosphotransferase (RPH) confers antibiotic resistance by conversion of RIF and ATP, to inactive phospho-RIF, AMP and Pi. Here we present the crystal structure of RPH from Listeria monocytogenes (RPH-Lm), which reveals that the enzyme is comprised of three domains: two substrate-binding domains (ATP-grasp and RIF-binding domains); and a smaller phosphate-carrying His swivel domain. Using solution small-angle X-ray scattering and mutagenesis, we reveal a mechanism where the swivel domain transits between the spatially distinct substrate-binding sites during catalysis. RPHs are previously uncharacterized dikinases that are widespread in environmental and pathogenic bacteria. These enzymes are members of a large unexplored group of bacterial enzymes with substrate affinities that have yet to be fully explored. Such an enzymatically complex mechanism of antibiotic resistance augments the spectrum of strategies used by bacteria to evade antimicrobial compounds.
- 22 April 2016
- Published by Springer Nature in Nature Communications
- Vol. 7 (1) , 11343
Open AccessRifampin phosphotransferase is an unusual antibiotic resistance kinase
Rifampin (RIF) phosphotransferase (RPH) confers antibiotic resistance by conversion of RIF and ATP, to inactive phospho-RIF, AMP and Pi. Here we present the crystal structure of RPH from Listeria monocytogenes (RPH-Lm), which reveals that the enzyme is comprised of three domains: two substrate-binding domains (ATP-grasp and RIF-binding domains); and a smaller phosphate-carrying His swivel domain. Using solution small-angle X-ray scattering and mutagenesis, we reveal a mechanism where the swivel domain transits between the spatially distinct substrate-binding sites during catalysis. RPHs are previously uncharacterized dikinases that are widespread in environmental and pathogenic bacteria. These enzymes are members of a large unexplored group of bacterial enzymes with substrate affinities that have yet to be fully explored. Such an enzymatically complex mechanism of antibiotic resistance augments the spectrum of strategies used by bacteria to evade antimicrobial compounds.
- Open Access
- 1 January 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (3) , 1175-1197
Structure-Function Analysis of a Mixed-linkage β-Glucanase/Xyloglucanase from the Key Ruminal Bacteroidetes Prevotella bryantii B14
- 1 January 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (3) , 1175-1197
Open AccessStructure-Function Analysis of a Mixed-linkage β-Glucanase/Xyloglucanase from the Key Ruminal Bacteroidetes Prevotella bryantii B14
- 1 October 2015
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 83 (12) , 2319-2325
Crystal structure of the Legionella pneumophila lem10 effector reveals a new member of the HD protein superfamily
Legionella pneumophila, the intracellular pathogen that can cause severe pneumonia known as Legionnaire's disease, translocates close to 300 effectors inside the host cell using Dot/Icm type IVB secretion system. The structure and function for the majority of these effector proteins remains unknown. Here, we present the crystal structure of the L. pneumophila effector Lem10. The structure reveals a multidomain organization with the largest C‐terminal domain showing strong structural similarity to the HD protein superfamily representatives. However, Lem10 lacks the catalytic His‐Asp residue pair and does not show any in vitro phosphohydrolase enzymatic activity, typical for HD proteins. While the biological function of Lem10 remains elusive, our analysis shows that similar distinct features are shared by a significant number of HD domains found in Legionella proteins, including the SidE family of effectors known to play an important role during infection. Taken together our data point to the presence of a specific group of non‐catalytic Legionella HD domains, dubbed LHDs, which are involved in pathogenesis. Proteins 2015; 83:2319–2325.
- 1 October 2015
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 83 (12) , 2319-2325
Crystal structure of the Legionella pneumophila lem10 effector reveals a new member of the HD protein superfamily
Legionella pneumophila, the intracellular pathogen that can cause severe pneumonia known as Legionnaire's disease, translocates close to 300 effectors inside the host cell using Dot/Icm type IVB secretion system. The structure and function for the majority of these effector proteins remains unknown. Here, we present the crystal structure of the L. pneumophila effector Lem10. The structure reveals a multidomain organization with the largest C‐terminal domain showing strong structural similarity to the HD protein superfamily representatives. However, Lem10 lacks the catalytic His‐Asp residue pair and does not show any in vitro phosphohydrolase enzymatic activity, typical for HD proteins. While the biological function of Lem10 remains elusive, our analysis shows that similar distinct features are shared by a significant number of HD domains found in Legionella proteins, including the SidE family of effectors known to play an important role during infection. Taken together our data point to the presence of a specific group of non‐catalytic Legionella HD domains, dubbed LHDs, which are involved in pathogenesis. Proteins 2015; 83:2319–2325.
- Open Access
- 1 September 2015
- Published by American Society for Microbiology in mBio
- Vol. 6 (4) , e00806-15
Structural and Functional Adaptation of Vancomycin Resistance VanT Serine Racemases
Vancomycin resistance in Gram-positive bacteria results from the replacement of the d -alanyl– d -alanine target of peptidoglycan precursors with d -alanyl– d -lactate or d -alanyl– d -serine ( d -Ala- d -Ser), to which vancomycin has low binding affinity. VanT is one of the proteins required for the production of d -Ala- d -Ser-terminating precursors by converting l -Ser to d -Ser. VanT is composed of two domains, an N-terminal membrane-bound domain, likely involved in l -Ser uptake, and a C-terminal cytoplasmic catalytic domain which is related to bacterial alanine racemases. To gain insight into the molecular function of VanT, the crystal structure of the catalytic domain of VanT G from VanG-type resistant Enterococcus faecalis BM4518 was determined. The structure showed significant similarity to type III pyridoxal 5′-phosphate (PLP)-dependent alanine racemases, which are essential for peptidoglycan synthesis. Comparative structural analysis between VanT G and alanine racemases as well as site-directed mutagenesis identified three specific active site positions centered around Asn 696 which are responsible for the l -amino acid specificity. This analysis also suggested that VanT racemases evolved from regular alanine racemases by acquiring additional selectivity toward serine while preserving that for alanine. The 4-fold-lower relative catalytic efficiency of VanT G against l -Ser versus l -Ala implied that this enzyme relies on its membrane-bound domain for l -Ser transport to increase the overall rate of d -Ser production. These findings illustrate how vancomycin pressure selected for molecular adaptation of a housekeeping enzyme to a bifunctional enzyme to allow for peptidoglycan remodeling, a strategy increasingly observed in antibiotic-resistant bacteria. IMPORTANCE Vancomycin is one of the drugs of last resort against Gram-positive antibiotic-resistant pathogens. However, bacteria have evolved a sophisticated mechanism which remodels the drug target, the d -alanine ending precursors in cell wall synthesis, into precursors terminating with d -lactate or d -serine, to which vancomycin has less affinity. d -Ser is synthesized by VanT serine racemase, which has two unusual characteristics: (i) it is one of the few serine racemases identified in bacteria and (ii) it contains a membrane-bound domain involved in l -Ser uptake. The structure of the catalytic domain of VanT G showed high similarity to alanine racemases, and we identified three specific active site substitutions responsible for l -Ser specificity. The data provide the molecular basis for VanT evolution to a bifunctional enzyme coordinating both transport and racemization. Our findings also illustrate the evolution of the essential alanine racemase into a vancomycin resistance enzyme in response to antibiotic pressure.
- 1 September 2015
- Published by American Society for Microbiology in mBio
- Vol. 6 (4) , e00806-15
Open AccessStructural and Functional Adaptation of Vancomycin Resistance VanT Serine Racemases
Vancomycin resistance in Gram-positive bacteria results from the replacement of the d -alanyl– d -alanine target of peptidoglycan precursors with d -alanyl– d -lactate or d -alanyl– d -serine ( d -Ala- d -Ser), to which vancomycin has low binding affinity. VanT is one of the proteins required for the production of d -Ala- d -Ser-terminating precursors by converting l -Ser to d -Ser. VanT is composed of two domains, an N-terminal membrane-bound domain, likely involved in l -Ser uptake, and a C-terminal cytoplasmic catalytic domain which is related to bacterial alanine racemases. To gain insight into the molecular function of VanT, the crystal structure of the catalytic domain of VanT G from VanG-type resistant Enterococcus faecalis BM4518 was determined. The structure showed significant similarity to type III pyridoxal 5′-phosphate (PLP)-dependent alanine racemases, which are essential for peptidoglycan synthesis. Comparative structural analysis between VanT G and alanine racemases as well as site-directed mutagenesis identified three specific active site positions centered around Asn 696 which are responsible for the l -amino acid specificity. This analysis also suggested that VanT racemases evolved from regular alanine racemases by acquiring additional selectivity toward serine while preserving that for alanine. The 4-fold-lower relative catalytic efficiency of VanT G against l -Ser versus l -Ala implied that this enzyme relies on its membrane-bound domain for l -Ser transport to increase the overall rate of d -Ser production. These findings illustrate how vancomycin pressure selected for molecular adaptation of a housekeeping enzyme to a bifunctional enzyme to allow for peptidoglycan remodeling, a strategy increasingly observed in antibiotic-resistant bacteria. IMPORTANCE Vancomycin is one of the drugs of last resort against Gram-positive antibiotic-resistant pathogens. However, bacteria have evolved a sophisticated mechanism which remodels the drug target, the d -alanine ending precursors in cell wall synthesis, into precursors terminating with d -lactate or d -serine, to which vancomycin has less affinity. d -Ser is synthesized by VanT serine racemase, which has two unusual characteristics: (i) it is one of the few serine racemases identified in bacteria and (ii) it contains a membrane-bound domain involved in l -Ser uptake. The structure of the catalytic domain of VanT G showed high similarity to alanine racemases, and we identified three specific active site substitutions responsible for l -Ser specificity. The data provide the molecular basis for VanT evolution to a bifunctional enzyme coordinating both transport and racemization. Our findings also illustrate the evolution of the essential alanine racemase into a vancomycin resistance enzyme in response to antibiotic pressure.
- Open Access
- 1 January 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (2) , 872-882
Structural and Functional Characterization of a Ketosteroid Transcriptional Regulator of Mycobacterium tuberculosis
- 1 January 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (2) , 872-882
Open AccessStructural and Functional Characterization of a Ketosteroid Transcriptional Regulator of Mycobacterium tuberculosis